These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11408781)

  • 1. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy.
    Wihlbäck AC; Sundström-Poromaa I; Nyberg S; Bäckström T
    Neuroendocrinology; 2001 Jun; 73(6):397-407. PubMed ID: 11408781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone serum concentrations and neurosteroid sensitivity during withdrawal from postmenopausal hormone therapy.
    Wihlbäck AC; Nyberg S; Andersson A; Bixo M; Bäckström T; Sundström-Poromaa I
    Gynecol Endocrinol; 2007 Oct; 23(10):590-6. PubMed ID: 17852417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
    Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
    Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T
    Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
    Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T
    Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy.
    Johnson JV; Davidson M; Archer D; Bachmann G
    Menopause; 2002; 9(1):16-22. PubMed ID: 11791082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
    Rees MC; Kuhl H; Engelstein M; Mattila L; Mäenpää J; Mustonen M;
    Climacteric; 2004 Mar; 7(1):23-32. PubMed ID: 15259280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
    Mattsson LA; Skouby SO; Heikkinen J; Vaheri R; Mäenpää J; Timonen U
    Climacteric; 2004 Mar; 7(1):59-69. PubMed ID: 15259284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    Baerug U; Winge T; Nordland G; Faber-Swensson E; Heldaas K; Norling B; Larsen S; Arce JC
    Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
    Cengiz B; Atabekoglu C; Cetinkaya E; Cengiz SD
    Maturitas; 2003 Dec; 46(4):301-6. PubMed ID: 14625127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
    Björn I; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström G; Bäckström T
    J Clin Endocrinol Metab; 2003 May; 88(5):2026-30. PubMed ID: 12727949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
    Gambacciani M; Spielmann D; Genazzani AR
    Gynecol Endocrinol; 2005 Aug; 21(2):65-73. PubMed ID: 16294457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
    Saure A; Planellas J; Poulsen HK; Jaszczak P
    Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström T
    Psychopharmacology (Berl); 2006 Aug; 187(2):209-21. PubMed ID: 16724185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens.
    Odmark IS; Bäckström T; Jonsson B; Bixo M
    Climacteric; 2004 Mar; 7(1):92-102. PubMed ID: 15259288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.